BEAM
Beam Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
USD26.33
-1.20 (-4.36%)
Rating:C-
Company Profile
CEO
John Evans
IPO Date
2020-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$27.73
Prev. Close
$27.53
Day Low
$26.19
Day High
$28.13
52W Low
$15.60
52W High
$38.26
Market Cap
$2.71B
Volume
2.74M